Search form

Sections

Food and Drug Administration

How to Stay Up-to-Date on Medical Device Safety and Recalls

Medical devices undeniably save and improve lives, but they can also malfunction or prove to be defective and pose serious risks for patients. So, as someone in the medical field, how do you stay up-to-date on medical device safety and recalls? The FDA does its best to keep doctors informed about medical device recalls, but communication from the FDA doesn’t always reach doctors soon enough.

Q&A with Leigh Turner, Part 3: Celltex Tries to Intimidate a Whistleblower

Bioethicist Leigh Turner describes how the stem cell company Celltex tried to intimidate him and his university when he asked the FDA to investigate the company.

Q&A with Leigh Turner, Part 2: Finding Ethical Quandaries Amid Academic Rivalries

Bioethicist Leigh Turner talks about why he sicced the FDA on Celltex and about academic rivalries in the world of bioethics.

Medify for Journalists: How a startup could help add context to your reporting

Medify got lots of attention at SXSW Interactive for its implications for patients -- but it could also be a great tool for reporting on medical studies.

Slap: Celltex Threatens University of Minnesota For Ethicist's FDA Letter

When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.

Stem Cells and the Lawsuit That May Shape Our Medical Future

Regenerative Sciences, a medical company that pioneered a procedure to treat orthopedic injuries using patients’ own stem cells, is fighting the Food and Drug Administration tooth and nail over a claim that human cells should be federally regulated as drugs, in a landmark case that has far-reaching implications for the future of regenerative medicine.

American Red Cross Fined $9.6 Million for Unsafe Blood Collection

The American Red Cross, the largest supplier of donated blood in the U.S., was fined $9.6 million after federal inspectors found hundreds of blood safety violations at 16 of the organization’s 36 blood collection centers nationwide.

Q&A with Keith Hoffman: Crunching Drug Data for Reporters on Deadline

A new company aims to clean up the FDA's messy data for reporting drug adverse events and market it to pharma and other businesses. Health reporters can benefit from the company's work, too.

"Blood Feud": How I Turned My Health Journalism Fellowship Into A Book Deal

Every once in a while, a story not only finds a reporter, it hounds her. That was the case with my new book about two friends who blew the whistle on one of the deadliest prescription drugs in U.S. history.

Full Disclosure: Universities Should Make Ghostwriting Disappear

Shannon Brownlee offers a not-so-modest proposal for universities to stamp out pharma ghostwriting benefiting researchers.

Pages

Data Reporting E-book - Download.

What makes your community healthy or unhealthy? Use our step-by-step data reporting guide to uncover untold stories!

Learn More »

CONNECT WITH THE COMMUNITY

  • Login or Join to connect with the community.

Popular Content

Member Activities

Becca Aaronson has shared a story

Read it.

Karen Bouffard's profile has been updated

Cindy Uken has shared a fellowship project

Read it.

Linda Marsa has shared a blog post

Read it.

Linda Marsa's profile has been updated

Log in to connect with the community

Follow Us

ReportingHealth